441 related articles for article (PubMed ID: 26022103)
1. Cognitive-behavioural therapy in medication-treated adults with attention-deficit/hyperactivity disorder and co-morbid psychopathology: a randomized controlled trial using multi-level analysis.
Young S; Khondoker M; Emilsson B; Sigurdsson JF; Philipp-Wiegmann F; Baldursson G; Olafsdottir H; Gudjonsson G
Psychol Med; 2015 Oct; 45(13):2793-804. PubMed ID: 26022103
[TBL] [Abstract][Full Text] [Related]
2. A randomized controlled trial reporting functional outcomes of cognitive-behavioural therapy in medication-treated adults with ADHD and comorbid psychopathology.
Young S; Emilsson B; Sigurdsson JF; Khondoker M; Philipp-Wiegmann F; Baldursson G; Olafsdottir H; Gudjonsson G
Eur Arch Psychiatry Clin Neurosci; 2017 Apr; 267(3):267-276. PubMed ID: 27752827
[TBL] [Abstract][Full Text] [Related]
3. Bright light therapy versus physical exercise to prevent co-morbid depression and obesity in adolescents and young adults with attention-deficit / hyperactivity disorder: study protocol for a randomized controlled trial.
Mayer JS; Hees K; Medda J; Grimm O; Asherson P; Bellina M; Colla M; Ibáñez P; Koch E; Martinez-Nicolas A; Muntaner-Mas A; Rommel A; Rommelse N; de Ruiter S; Ebner-Priemer UW; Kieser M; Ortega FB; Thome J; Buitelaar JK; Kuntsi J; Ramos-Quiroga JA; Reif A; Freitag CM
Trials; 2018 Feb; 19(1):140. PubMed ID: 29482662
[TBL] [Abstract][Full Text] [Related]
4. Cognitive behaviour therapy in medication-treated adults with ADHD and persistent symptoms: a randomized controlled trial.
Emilsson B; Gudjonsson G; Sigurdsson JF; Baldursson G; Einarsson E; Olafsdottir H; Young S
BMC Psychiatry; 2011 Jul; 11():116. PubMed ID: 21787431
[TBL] [Abstract][Full Text] [Related]
5. Impact of a behavioural sleep intervention on symptoms and sleep in children with attention deficit hyperactivity disorder, and parental mental health: randomised controlled trial.
Hiscock H; Sciberras E; Mensah F; Gerner B; Efron D; Khano S; Oberklaid F
BMJ; 2015 Jan; 350():h68. PubMed ID: 25646809
[TBL] [Abstract][Full Text] [Related]
6. Psychoeducation for adults with attention deficit hyperactivity disorder vs. cognitive behavioral group therapy: a randomized controlled pilot study.
Vidal R; Bosch R; Nogueira M; Gómez-Barros N; Valero S; Palomar G; Corrales M; Richarte V; Mena B; Casas M; Ramos-Quiroga JA
J Nerv Ment Dis; 2013 Oct; 201(10):894-900. PubMed ID: 24080677
[TBL] [Abstract][Full Text] [Related]
7. Atomoxetine treatment of attention-deficit/hyperactivity disorder in young adults with assessment of functional outcomes: a randomized, double-blind, placebo-controlled clinical trial.
Durell TM; Adler LA; Williams DW; Deldar A; McGough JJ; Glaser PE; Rubin RL; Pigott TA; Sarkis EH; Fox BK
J Clin Psychopharmacol; 2013 Feb; 33(1):45-54. PubMed ID: 23277268
[TBL] [Abstract][Full Text] [Related]
8. Cognitive behavioral therapy for adults with attention-deficit hyperactivity disorder: study protocol for a randomized controlled trial.
Huang F; Qian Q; Wang Y
Trials; 2015 Apr; 16():161. PubMed ID: 25873090
[TBL] [Abstract][Full Text] [Related]
9. Cognitive-behavioral therapy for ADHD in medication-treated adults with continued symptoms.
Safren SA; Otto MW; Sprich S; Winett CL; Wilens TE; Biederman J
Behav Res Ther; 2005 Jul; 43(7):831-42. PubMed ID: 15896281
[TBL] [Abstract][Full Text] [Related]
10. Neurofeedback, sham neurofeedback, and cognitive-behavioural group therapy in adults with attention-deficit hyperactivity disorder: a triple-blind, randomised, controlled trial.
Schönenberg M; Wiedemann E; Schneidt A; Scheeff J; Logemann A; Keune PM; Hautzinger M
Lancet Psychiatry; 2017 Sep; 4(9):673-684. PubMed ID: 28803030
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of one-year pharmacological treatment of adult attention-deficit/hyperactivity disorder (ADHD): an open-label prospective study of time in treatment, dose, side-effects and comorbidity.
Fredriksen M; Dahl AA; Martinsen EW; Klungsøyr O; Haavik J; Peleikis DE
Eur Neuropsychopharmacol; 2014 Dec; 24(12):1873-84. PubMed ID: 25453480
[TBL] [Abstract][Full Text] [Related]
12. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
Spencer TJ; Wilens TE; Biederman J; Weisler RH; Read SC; Pratt R
Clin Ther; 2006 Feb; 28(2):266-79. PubMed ID: 16678648
[TBL] [Abstract][Full Text] [Related]
13. Group therapy for adolescents with attention-deficit/hyperactivity disorder: a randomized controlled trial.
Vidal R; Castells J; Richarte V; Palomar G; García M; Nicolau R; Lazaro L; Casas M; Ramos-Quiroga JA
J Am Acad Child Adolesc Psychiatry; 2015 Apr; 54(4):275-82. PubMed ID: 25791144
[TBL] [Abstract][Full Text] [Related]
14. Protocol for a proof of concept randomized controlled trial of cognitive-behavioural therapy for adult ADHD as a supplement to treatment as usual, compared with treatment as usual alone.
Dittner AJ; Rimes KA; Russell AJ; Chalder T
BMC Psychiatry; 2014 Sep; 14():248. PubMed ID: 25207986
[TBL] [Abstract][Full Text] [Related]
15. Mindfulness based cognitive therapy versus treatment as usual in adults with attention deficit hyperactivity disorder (ADHD).
Janssen L; Kan CC; Carpentier PJ; Sizoo B; Hepark S; Grutters J; Donders R; Buitelaar JK; Speckens AE
BMC Psychiatry; 2015 Sep; 15():216. PubMed ID: 26373634
[TBL] [Abstract][Full Text] [Related]
16. Does the treatment of anxiety in children with Attention-Deficit/Hyperactivity Disorder (ADHD) using cognitive behavioral therapy improve child and family outcomes? Protocol for a randomized controlled trial.
Sciberras E; Efron D; Patel P; Mulraney M; Lee KJ; Mihalopoulos C; Engel L; Rapee RM; Anderson V; Nicholson JM; Schembri R; Hiscock H
BMC Psychiatry; 2019 Nov; 19(1):359. PubMed ID: 31722690
[TBL] [Abstract][Full Text] [Related]
17. A randomized controlled trial of cognitive behavioral therapy for ADHD in medication-treated adolescents.
Sprich SE; Safren SA; Finkelstein D; Remmert JE; Hammerness P
J Child Psychol Psychiatry; 2016 Nov; 57(11):1218-1226. PubMed ID: 26990084
[TBL] [Abstract][Full Text] [Related]
18. Integrated cognitive behavioral therapy for ADHD in adult substance use disorder patients: Results of a randomized clinical trial.
van Emmerik-van Oortmerssen K; Vedel E; Kramer FJ; Blankers M; Dekker JJM; van den Brink W; Schoevers RA
Drug Alcohol Depend; 2019 Apr; 197():28-36. PubMed ID: 30769263
[TBL] [Abstract][Full Text] [Related]
19. Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder.
Wilens TE; Biederman J; Prince J; Spencer TJ; Faraone SV; Warburton R; Schleifer D; Harding M; Linehan C; Geller D
Am J Psychiatry; 1996 Sep; 153(9):1147-53. PubMed ID: 8780417
[TBL] [Abstract][Full Text] [Related]
20. One-year follow-up of the effectiveness and mediators of cognitive behavioural therapy among adults with attention-deficit/hyperactivity disorder: secondary outcomes of a randomised controlled trial.
Pan MR; Dong M; Zhang SY; Liu L; Li HM; Wang YF; Qian QJ
BMC Psychiatry; 2024 Mar; 24(1):207. PubMed ID: 38491411
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
